The Bordetella adenylate cyclase toxin-hemolysin (CyaA) targets phagocytes expressing the alpha(M)beta2 integrin (CD11b/CD18), permeabilizes their membranes by forming small cation-selective pores, and delivers into cells a calmodulin-activated adenylate cyclase (AC) enzyme that dissipates cytosolic ATP into cAMP. We describe here a third activity of CyaA that yields elevation of cytosolic calcium concentration ([Ca2+]i) in target cells. The CyaA-mediated [Ca2+]i increase in CD11b+ J774A.1 monocytes was inhibited by extracellular La3+ ions but not by nifedipine, SK&F 96365, flunarizine, 2-aminoethyl diphenylborinate, or thapsigargin, suggesting that influx of Ca2+ into cells was not because of receptor signaling or opening of conventional calcium channels by cAMP. Compared with intact CyaA, a CyaA-AC- toxoid unable to generate cAMP promoted a faster, albeit transient, elevation of [Ca2+]i. This was not because of cell permeabilization by the CyaA hemolysin pores, because a mutant exhibiting a strongly enhanced pore-forming activity (CyaA-E509K/E516K), but unable to deliver the AC domain into cells, was also unable to elicit a [Ca2+]i increase. Further mutations interfering with AC translocation into cells, such as proline substitutions of glutamate residues 509 or 570 or deletion of the AC domain as such, reduced or ablated the [Ca2+]i-elevating capacity of CyaA. Moreover, structural alterations within the AC domain, because of insertion of various oligopeptides, differently modulated the kinetics and extent of Ca2+ influx elicited by the respective AC- toxoids. Hence, the translocating AC polypeptide itself appears to participate in formation of a novel type of membrane path for calcium ions, contributing to action of CyaA in an unexpected manner.

Department of Genetics and Microbiology Faculty of Science Charles University CZ 128 44 Prague

000      

00000naa 2200000 a 4500

001      

bmc09003320

003      

CZ-PrNML

005      

20111210152723.0

008      

091119s2007 xxu e eng||

009      

AR

041    0_

$a eng

044    __

$a xxu

100    1_

$a Fišer, Radovan. $7 _AN035431

245    10

$a Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities / $c Fiser R, Masín J, Basler M, Krusek J, Spuláková V, Konopásek I, Sebo P

314    __

$a Department of Genetics and Microbiology, Faculty of Science, Charles University, CZ-128 44, Prague 2

520    9_

$a The Bordetella adenylate cyclase toxin-hemolysin (CyaA) targets phagocytes expressing the alpha(M)beta2 integrin (CD11b/CD18), permeabilizes their membranes by forming small cation-selective pores, and delivers into cells a calmodulin-activated adenylate cyclase (AC) enzyme that dissipates cytosolic ATP into cAMP. We describe here a third activity of CyaA that yields elevation of cytosolic calcium concentration ([Ca2+]i) in target cells. The CyaA-mediated [Ca2+]i increase in CD11b+ J774A.1 monocytes was inhibited by extracellular La3+ ions but not by nifedipine, SK&F 96365, flunarizine, 2-aminoethyl diphenylborinate, or thapsigargin, suggesting that influx of Ca2+ into cells was not because of receptor signaling or opening of conventional calcium channels by cAMP. Compared with intact CyaA, a CyaA-AC- toxoid unable to generate cAMP promoted a faster, albeit transient, elevation of [Ca2+]i. This was not because of cell permeabilization by the CyaA hemolysin pores, because a mutant exhibiting a strongly enhanced pore-forming activity (CyaA-E509K/E516K), but unable to deliver the AC domain into cells, was also unable to elicit a [Ca2+]i increase. Further mutations interfering with AC translocation into cells, such as proline substitutions of glutamate residues 509 or 570 or deletion of the AC domain as such, reduced or ablated the [Ca2+]i-elevating capacity of CyaA. Moreover, structural alterations within the AC domain, because of insertion of various oligopeptides, differently modulated the kinetics and extent of Ca2+ influx elicited by the respective AC- toxoids. Hence, the translocating AC polypeptide itself appears to participate in formation of a novel type of membrane path for calcium ions, contributing to action of CyaA in an unexpected manner.

650    _2

$a financování organizované $7 D005381

650    _2

$a adenosintrifosfát $x metabolismus $7 D000255

650    _2

$a adenylátcyklasy $x metabolismus $7 D000262

650    _2

$a adenylátcyklasový toxin $x genetika $x chemie $x izolace a purifikace $x metabolismus $7 D037361

650    _2

$a substituce aminokyselin $7 D019943

650    _2

$a zvířata $7 D000818

650    _2

$a antigeny CD11b $x fyziologie $7 D039481

650    _2

$a biologický transport $7 D001692

650    _2

$a vápník $x metabolismus $7 D002118

650    _2

$a katalýza $7 D002384

650    _2

$a buněčné linie $7 D002460

650    _2

$a buněčná membrána $x fyziologie $7 D002462

650    _2

$a AMP cyklický $x metabolismus $7 D000242

650    _2

$a hemolýza $7 D006461

650    _2

$a makrofágy $x fyziologie $7 D008264

650    _2

$a myši $7 D051379

650    _2

$a monocyty $x fyziologie $7 D009000

650    _2

$a mutageneze cílená $7 D016297

650    _2

$a polymerázová řetězová reakce $7 D016133

650    _2

$a rekombinantní proteiny $x chemie $x izolace a purifikace $x metabolismus $7 D011994

650    _2

$a ovce $7 D012756

700    1_

$a Mašín, Jiří. $7 _BN005473

700    1_

$a Basler, Marek $7 xx0106858

700    1_

$a Krůšek, Jan, $d 1961- $7 xx0101031

700    1_

$a Špuláková, Veronika $7 xx0127226

700    1_

$a Konopásek, Ivo, $d 1958- $7 _BN005474

700    1_

$a Šebo, Peter, $d 1960- $7 uk2008403106

773    0_

$w MED00002546 $t The journal of biological chemistry $g Roč. 282, č. 5 (2007), s. 2808-2820 $x 0021-9258

910    __

$a ABA008 $b x $y 9

990    __

$a 20090824163150 $b ABA008

991    __

$a 20091229083059 $b ABA008

999    __

$a ok $b bmc $g 692488 $s 554402

BAS    __

$a 3

BMC    __

$a 2007 $b 282 $c 5 $d 2808-2820 $i 0021-9258 $m The Journal of biological chemistry $x MED00002546

LZP    __

$a 2009-B4/vtme